The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EORTC-2129-BCG: Elacestrant for treating ER+/HER2- breast cancer patients with ctDNA relapse (TREAT ctDNA).
 
Michail Ignatiadis
Consulting or Advisory Role - Daichi; Gilead Sciences; Menarini Group; Novartis; Rejuveron senescence therapeutics; Seagen
Research Funding - Inivata (Inst); Natera (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent entitled method for determining sensitivity to a CDK4/6 inh filed the 18 05 16 by Universite Libre de Bruxelles, Application No/Patent No 16170146.1-1403
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); Novartis; Roche (Inst)
 
Emmanouil Saloustros
Honoraria - AstraZeneca/Greece; GlaxoSmithKline; IPSEN; MERCK, SHARP & DOHME
Consulting or Advisory Role - AstraZeneca; Genesis Pharma; Gilead Sciences; Integris; MERCK, SHARP & DOHME; Pfizer Hellas; Pharmaserve/Lilly
Speakers' Bureau - Amgen; Ipsen; Pfizer
Travel, Accommodations, Expenses - MERCK, SHARP & DOHME; MERCK, SHARP & DOHME; Pfizer; Pfizer Hellas
 
Ana Joaquim
No Relationships to Disclose
 
Fanny Grillet
No Relationships to Disclose
 
Yiola Marcou
Travel, Accommodations, Expenses - Roche
 
Sonia Pernas
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - SOLTI
 
Patrick Neven
Consulting or Advisory Role - Agendia (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Gilead Sciences (Inst); Lilly (Inst); Menarini (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Radius Health (Inst); Roche (Inst); Roche (Inst)
Research Funding - Kom op Tegen Kanker (Inst); Think Pink (Inst)
Travel, Accommodations, Expenses - Gilead Sciences (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
 
Sonia Berron
No Relationships to Disclose
 
Jose Ponce-Lorenzo
Honoraria - Agendia; AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pfizer; Seagen
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Novartis; Pierre Fabré; Roche; Seagen
 
Catharina Menke-van Der Houven Van Oordt
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
 
Catherine Kelly
Honoraria - Daiichi Sankyo Europe GmbH; Exact Sciences; Gilead Sciences; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; pfizer; Roche
Other Relationship - Roche
 
Mathias Fehr
Stock and Other Ownership Interests - Novartis; Roche
Travel, Accommodations, Expenses - Gilead Sciences; PharmaMar
 
Evangelia Razis
Honoraria - AstraZeneca; ESMO; Gilead Sciences; Novartis; SERVIER
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Novartis/Ipsen; Servier/Pfizer
Research Funding - AstraZeneca; Exelixis; IQvia; MSD; PPD Global; Tesaro
Travel, Accommodations, Expenses - Astra Zenec; AstraZeneca; Gilead Sciences; Integris; Karyo; Pfizer; Servier
 
Theodoros Foukakis
Honoraria - UpToDate
Research Funding - AstraZeneca (Inst); Novartis (Inst); Veracyte (Inst)
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Francois Clement Bidard
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Foresight Diagnostics; Inatherys; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Roche; SAGA Diagnostics
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Roche
Research Funding - GE Healthcare (Inst); Menarini Silicon Biosystems (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Personalis (Inst); Pfizer (Inst); Prolynx (Inst); Roche (Inst); SAGA Diagnostics (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - ESR1 & MSI detection techniques (patents) (Inst); Prognosis assessment by a digital pathology assay in early breast cancer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer; Roche
 
Coralie Poncet
No Relationships to Disclose
 
Wolfgang Janni
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Roche; Seagen
Research Funding - Amgen (Inst); Janssen Diagnostics; Lilly (Inst); Menarini Silicon Biosystems; NeoGenomics Laboratories (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; Novartis; Pfizer; Roche